| Thomas Shane Bolan, LCSW, CSAC | |
|
3207 Laura Ln Ste 100, Middleton, WI 53562-1428 | |
| (608) 290-0956 | |
| Not Available |
| Full Name | Thomas Shane Bolan |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 3207 Laura Ln Ste 100, Middleton, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770703431 | NPI | - | NPPES |
| Entity Name | Hanna Medical Clinic Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902342868 PECOS PAC ID: 6901182955 Enrollment ID: O20170406000676 |
News Archive
According to a study from Dutch researchers, some men are allergic to their own semen, developing a mysterious flu-like illness after they have an ejaculation. The condition, known as post-orgasmic illness syndrome or POIS, has been documented since 2002. It manifests as feverishness, runny nose, extreme fatigue and burning eyes, which can last for up to a week.
Shooting steady pulses of electricity through slender electrodes into a brain area that controls complex behaviors has proven to be effective against several therapeutically stubborn neurological and neuropsychiatric disorders. Now, a new study has found that this technique, called deep brain stimulation (DBS), targets the same class of neuronal cells that are known to respond to physical exercise and drugs such as Prozac.
Emergent Financial Group, Inc. today announced the completion of a $11.8 million private placement transaction for Tenex Health Inc., a California-based medical technology company developing the FAST Procedure (Focused Aspiration of Scar Tissue) for the treatment of tendon injuries.
Midatech Group Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, and MonoSol Rx, the leader in developing and manufacturing pharmaceutical films based on its proprietary PharmFilm drug delivery technology, today announced the filing of a provisional US patent application for "Nanoparticle Film Delivery Systems." The applications submitted to the United States Patent and Trademark Office (USPTO) relate to therapeutic uses of nanoparticle-based proteins and peptides delivered in pharmaceutical films.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Shane Bolan, LCSW, CSAC 3207 Laura Ln Ste 120, Middleton, WI 53562-1428 Ph: (608) 752-2930 | Thomas Shane Bolan, LCSW, CSAC 3207 Laura Ln Ste 100, Middleton, WI 53562-1428 Ph: (608) 290-0956 |
News Archive
According to a study from Dutch researchers, some men are allergic to their own semen, developing a mysterious flu-like illness after they have an ejaculation. The condition, known as post-orgasmic illness syndrome or POIS, has been documented since 2002. It manifests as feverishness, runny nose, extreme fatigue and burning eyes, which can last for up to a week.
Shooting steady pulses of electricity through slender electrodes into a brain area that controls complex behaviors has proven to be effective against several therapeutically stubborn neurological and neuropsychiatric disorders. Now, a new study has found that this technique, called deep brain stimulation (DBS), targets the same class of neuronal cells that are known to respond to physical exercise and drugs such as Prozac.
Emergent Financial Group, Inc. today announced the completion of a $11.8 million private placement transaction for Tenex Health Inc., a California-based medical technology company developing the FAST Procedure (Focused Aspiration of Scar Tissue) for the treatment of tendon injuries.
Midatech Group Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, and MonoSol Rx, the leader in developing and manufacturing pharmaceutical films based on its proprietary PharmFilm drug delivery technology, today announced the filing of a provisional US patent application for "Nanoparticle Film Delivery Systems." The applications submitted to the United States Patent and Trademark Office (USPTO) relate to therapeutic uses of nanoparticle-based proteins and peptides delivered in pharmaceutical films.
› Verified 1 days ago